Collective bargaining tempers Merck KGaA's 10% German workforce cut
This article was originally published in Scrip
Merck KGaA has announced that it will reduce its workforce in its home country of Germany by around 10%, or 1,100 positions, but it has agreed in the main to hold off from making forced redundancies and outsourcing positions, and from relocating its financial services activities abroad.
You may also be interested in...
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.